3Spine wins FDA IDE for spine implant
3Spine announced today that it received FDA investigational device exemption (IDE) for its Motus spinal implant device.
Stay updated with breaking news from Justin Eggleton. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
3Spine announced today that it received FDA investigational device exemption (IDE) for its Motus spinal implant device.
Share this article Share this article WASHINGTON, May 12, 2021 /PRNewswire/ -- MCRA, LLC, the leading privately held medical device and biologics advisory firm and Clinical Research Organization (CRO) integrating U.S. and International Regulatory, Clinical Research, Reimbursement, Healthcare Compliance, Quality Assurance, and Medical Device Cybersecurity, is pleased to announce its role in the successful management and execution of Simplify Medical's two clinical studies and approvals by the U.S. Food and Drug Administration (FDA) for the Simplify Cervical Artificial Disc (Simplify Disc) to ...